Gattinger, P.; Kratzer, B.; Sehgal, A.N.A.; Ohradanova-Repic, A.; Gebetsberger, L.; Tajti, G.; Focke-Tejkl, M.; Schaar, M.; Fuhrmann, V.; Petrowitsch, L.;
et al. Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model. Vaccines 2024, 12, 229.
https://doi.org/10.3390/vaccines12030229
AMA Style
Gattinger P, Kratzer B, Sehgal ANA, Ohradanova-Repic A, Gebetsberger L, Tajti G, Focke-Tejkl M, Schaar M, Fuhrmann V, Petrowitsch L,
et al. Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model. Vaccines. 2024; 12(3):229.
https://doi.org/10.3390/vaccines12030229
Chicago/Turabian Style
Gattinger, Pia, Bernhard Kratzer, Al Nasar Ahmed Sehgal, Anna Ohradanova-Repic, Laura Gebetsberger, Gabor Tajti, Margarete Focke-Tejkl, Mirjam Schaar, Verena Fuhrmann, Lukas Petrowitsch,
and et al. 2024. "Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model" Vaccines 12, no. 3: 229.
https://doi.org/10.3390/vaccines12030229
APA Style
Gattinger, P., Kratzer, B., Sehgal, A. N. A., Ohradanova-Repic, A., Gebetsberger, L., Tajti, G., Focke-Tejkl, M., Schaar, M., Fuhrmann, V., Petrowitsch, L., Keller, W., Högler, S., Stockinger, H., Pickl, W. F., & Valenta, R.
(2024). Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model. Vaccines, 12(3), 229.
https://doi.org/10.3390/vaccines12030229
